drugset / Trial / NCT05566834

Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer

NCT05566834

Phase 1 Unknown 36 enrolled Minneamrita Therapeutics LLC
NaSingle-groupOpen-labelTreatment

Summary

A Phase 1, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™ Capsules given alone or in combination with paclitaxel in patients with Advanced Gastric Cancer.

Timeline

Start
2020-11-02
Primary completion
2024-06
Completion
2024-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Minnelide Small molecule

Indications